ID

18421

Beschreibung

Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT00184002

Link

https://clinicaltrials.gov/show/NCT00184002

Stichworte

Versionen (1)
  1. 04.11.16 04.11.16 -
Hochgeladen am

4. November 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Non-Hodgkin's Lymphoma NCT00184002

Englisch

Eligibility Non-Hodgkin's Lymphoma NCT00184002

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
pathologic diagnosis of non-hodgkin's lymphoma of b-cell origin: follicular large cell, diffuse large cell (including all b-cell variants), burkitt or burkitt-like lymphoma
Beschreibung

B-Cell Lymphomas | Lymphoma, Large-Cell, Follicular | adult diffuse large cell lymphoma | Diffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Burkitt-like lymphoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0079731
UMLS CUI [2]
C0079745
UMLS CUI [3]
C0278762
UMLS CUI [4]
C0079744
UMLS CUI [5]
C0006413
UMLS CUI [6]
C1368771
all stages of disease
Beschreibung

TNM clinical staging

Datentyp

boolean

Alias
UMLS CUI [1]
C3258246
measurable or evaluable tumor parameter(s)
Beschreibung

Neoplasm parameter Measurable | Neoplasm parameter Evaluable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C0449381
UMLS CUI [1,3]
C1513040
UMLS CUI [2,1]
C0027651
UMLS CUI [2,2]
C0449381
UMLS CUI [2,3]
C0220825
age greater than 17 years old
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
karnofsky performance status greater or equal to 50%
Beschreibung

Karnofsky Performance Status

Datentyp

boolean

Alias
UMLS CUI [1]
C0206065
agc greater or equal to 1.0; platelets greater or equal to 75,000(unless abnormal because of lymphoma)
Beschreibung

Absolute neutrophil count | Platelet Count measurement | Abnormal platelets Due to Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
UMLS CUI [3,1]
C0151854
UMLS CUI [3,2]
C0678226
UMLS CUI [3,3]
C0024299
bilirubin less or equal to 2.0; sgot less or equal to 3 times upper limit of normal (unless abnormal because of lymphoma)
Beschreibung

Serum total bilirubin measurement | Aspartate aminotransferase measurement | AST/SGOT level abnormal Due to Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201899
UMLS CUI [3,1]
C0580475
UMLS CUI [3,2]
C0678226
UMLS CUI [3,3]
C0024299
creatinine less or equal to 2.0 or creatinine clearance greater or equal to 60 ml/min (unless abnormal because of lymphoma)
Beschreibung

Creatinine measurement, serum | Creatinine clearance measurement | Serum creatinine abnormal Due to Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0373595
UMLS CUI [3,1]
C0438243
UMLS CUI [3,2]
C0678226
UMLS CUI [3,3]
C0024299
lvef greater or equal to 45%
Beschreibung

Left ventricular ejection fraction

Datentyp

boolean

Alias
UMLS CUI [1]
C0428772
concurrent rt with or without steroids for emergency conditions secondary to lymphoma (i.e., cns tumor, cord compression)are permitted
Beschreibung

Therapeutic radiology procedure | Steroids | Emergency Situation Secondary to Lymphoma | Central Nervous System Neoplasms | Compression of spinal cord

Datentyp

boolean

Alias
UMLS CUI [1]
C1522449
UMLS CUI [2]
C0038317
UMLS CUI [3,1]
C0013956
UMLS CUI [3,2]
C0175668
UMLS CUI [3,3]
C0024299
UMLS CUI [4]
C0085136
UMLS CUI [5]
C0037926
men and women of childbearing potential must agree to use adequate birth control for the duration of the therapy and for 3 months after completion of therapy
Beschreibung

Fertility Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
signed informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior systemic cytotoxic therapy or rt for lymphoma
Beschreibung

systemic therapy cytotoxic Lymphoma | prior radiation therapy Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C1511636
UMLS CUI [1,3]
C0024299
UMLS CUI [2,1]
C0279134
UMLS CUI [2,2]
C0024299
second active tumor, other than non-melanomatous skin ca and in-situ cervical cancer
Beschreibung

Neoplasms, Second Primary | Skin carcinoma | Carcinoma in situ of uterine cervix

Datentyp

boolean

Alias
UMLS CUI [1]
C0085183
UMLS CUI [2]
C0699893
UMLS CUI [3]
C0851140
hiv seropositive
Beschreibung

HIV Seropositivity

Datentyp

boolean

Alias
UMLS CUI [1]
C0019699
primary cns lymphoma
Beschreibung

Primary central nervous system lymphoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0280803
pregnant or nursing women
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
unable to comply with the requirements of the protocol, or unable to provide adequate informed consent, in the opinion of the pi
Beschreibung

Protocol Compliance Unable | Informed Consent Unable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0525058
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C1299582
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Non-Hodgkin's Lymphoma NCT00184002

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
B-Cell Lymphomas | Lymphoma, Large-Cell, Follicular | adult diffuse large cell lymphoma | Diffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Burkitt-like lymphoma
Item
pathologic diagnosis of non-hodgkin's lymphoma of b-cell origin: follicular large cell, diffuse large cell (including all b-cell variants), burkitt or burkitt-like lymphoma
boolean
C0079731 (UMLS CUI [1])
C0079745 (UMLS CUI [2])
C0278762 (UMLS CUI [3])
C0079744 (UMLS CUI [4])
C0006413 (UMLS CUI [5])
C1368771 (UMLS CUI [6])
TNM clinical staging
Item
all stages of disease
boolean
C3258246 (UMLS CUI [1])
Neoplasm parameter Measurable | Neoplasm parameter Evaluable
Item
measurable or evaluable tumor parameter(s)
boolean
C0027651 (UMLS CUI [1,1])
C0449381 (UMLS CUI [1,2])
C1513040 (UMLS CUI [1,3])
C0027651 (UMLS CUI [2,1])
C0449381 (UMLS CUI [2,2])
C0220825 (UMLS CUI [2,3])
Age
Item
age greater than 17 years old
boolean
C0001779 (UMLS CUI [1])
Karnofsky Performance Status
Item
karnofsky performance status greater or equal to 50%
boolean
C0206065 (UMLS CUI [1])
Absolute neutrophil count | Platelet Count measurement | Abnormal platelets Due to Lymphoma
Item
agc greater or equal to 1.0; platelets greater or equal to 75,000(unless abnormal because of lymphoma)
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0151854 (UMLS CUI [3,1])
C0678226 (UMLS CUI [3,2])
C0024299 (UMLS CUI [3,3])
Serum total bilirubin measurement | Aspartate aminotransferase measurement | AST/SGOT level abnormal Due to Lymphoma
Item
bilirubin less or equal to 2.0; sgot less or equal to 3 times upper limit of normal (unless abnormal because of lymphoma)
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0580475 (UMLS CUI [3,1])
C0678226 (UMLS CUI [3,2])
C0024299 (UMLS CUI [3,3])
Creatinine measurement, serum | Creatinine clearance measurement | Serum creatinine abnormal Due to Lymphoma
Item
creatinine less or equal to 2.0 or creatinine clearance greater or equal to 60 ml/min (unless abnormal because of lymphoma)
boolean
C0201976 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
C0438243 (UMLS CUI [3,1])
C0678226 (UMLS CUI [3,2])
C0024299 (UMLS CUI [3,3])
Left ventricular ejection fraction
Item
lvef greater or equal to 45%
boolean
C0428772 (UMLS CUI [1])
Therapeutic radiology procedure | Steroids | Emergency Situation Secondary to Lymphoma | Central Nervous System Neoplasms | Compression of spinal cord
Item
concurrent rt with or without steroids for emergency conditions secondary to lymphoma (i.e., cns tumor, cord compression)are permitted
boolean
C1522449 (UMLS CUI [1])
C0038317 (UMLS CUI [2])
C0013956 (UMLS CUI [3,1])
C0175668 (UMLS CUI [3,2])
C0024299 (UMLS CUI [3,3])
C0085136 (UMLS CUI [4])
C0037926 (UMLS CUI [5])
Fertility Contraceptive methods
Item
men and women of childbearing potential must agree to use adequate birth control for the duration of the therapy and for 3 months after completion of therapy
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Informed Consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
systemic therapy cytotoxic Lymphoma | prior radiation therapy Lymphoma
Item
prior systemic cytotoxic therapy or rt for lymphoma
boolean
C1515119 (UMLS CUI [1,1])
C1511636 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
C0279134 (UMLS CUI [2,1])
C0024299 (UMLS CUI [2,2])
Neoplasms, Second Primary | Skin carcinoma | Carcinoma in situ of uterine cervix
Item
second active tumor, other than non-melanomatous skin ca and in-situ cervical cancer
boolean
C0085183 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
C0851140 (UMLS CUI [3])
HIV Seropositivity
Item
hiv seropositive
boolean
C0019699 (UMLS CUI [1])
Primary central nervous system lymphoma
Item
primary cns lymphoma
boolean
C0280803 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or nursing women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Protocol Compliance Unable | Informed Consent Unable
Item
unable to comply with the requirements of the protocol, or unable to provide adequate informed consent, in the opinion of the pi
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video